Literature Reviews
doi: 10.25005/2074-0581-2019-21-1-136-140 10.25005/2074-0581-2019-21-1-136-140
COMPLEX DIAGNOSTICS AND METHODS OF TREATMENT OF THE SYNDROME OF ENTERAL INSUFFICIENCY IN PATIENTS WITH ACUTE PANCREATITIS

S.G. Ali-Zade, Sh.K. Nazarov, P.K. Kholmatov, R.A. Dodikhudoev

Department of Surgical Diseases № 1, Avicenna Tajik State Medical University, Dushanbe, Republic of Tajikistan

In the given literary review are discussed the actual problems of diagnosis and treatment of the syndrome of enteral insufficiency, occurs against the background of acute pancreatitis. In patients suffering from acute pancreatitis, up to 80% of cases, enteral insufficiency syndrome (EIS) occurs, aggravating the processes of endotoxicosis. To date, the timely detection of EIS through the use of modern methods of research of detecting disorders is still considered to be influencing disorders of intestinal function. For full diagnosis of EIS are modern laboratory and instrumental studies, such as radiographic, ultrasound, electrogastroenterography, and also the bacteriological research of feces. Prokinetics (ganaton, metoclopramide derivatives, etc.), early intestinal lavage, and cleansing enemas are more often used to stimulate the intestine. It is considered that such a combined application of treatment methods has a great effect against enteroparesis which contributes to the consolation of the results of the EIS in acute pancreatitis. It should be noted that recently a great interest in scientists cause the issues of early enteral probe feeding. It was determined that the best results were the treatment of patients with the use of enteral probe feeding in combination with selective decontamination of the gastrointestinal tract. Thus, therapeutic measures for EIS are aimed at resolving enteroparesis. However, these therapeutic measures need further research as well as aspects of preventing the development of functional bowel disorders.

Keywords: Enteral insufficiency syndrome, acute pancreatitis, diagnosis, treatment.

Download file:

References
  1. Capurso G, Zerboni G, Signoretti M, Valente R, Stigliano S, Piciucchi M, et al. Role of the gut barrier in acute pancreatitis. J Clin Gastroenterol. 2012;46:46- 51
  2. Grant JP. Nutritional support in acute and chronic pancreatitis. Surg Clin North Am. 2011;4:805-20.
  3. Kylanpaa ML, Repo H, Puolakkainen PA. Inflammation and immunosuppression in severe acute pancreatitis. World Journal of Gastroenterology. 2010;16(23):2867-72.
  4. Shyu JY, Sainani NI, Sahni VA, Chick JF, Chauhan NR, Conwell DL, et al. Necrotizing pancreatitis: diagnosis, imaging, and intervention. RadioGraphics. 2014;34(5):1218-39.
  5. Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidencebased guidelines for the management of acute pancreatitis. Pancreatology. 2013;13(4):1-15
  6. Minushkin ON, Loshchinina YuN. Effektivnost’ primeneniya preparata Ganaton v lechenii bol’nykh GERB [The effectiveness of the drug Ganaton in the treatment of patients with GERD]. Effektivnaya farmakoterapiya v gastroenterologii. 2008;3:20-4.
  7. Rummo OO. Intraintestinal’naya terapiya sindroma enteral’noy nedostatochnosti pri peritonite, kishechnoy neprokhodimosti i destruktivnom pankreatite [Intraintestinal therapy of enteral insufficiency syndrome in peritonitis, intestinal obstruction and destructive pancreatitis]. Meditsinskiy zhurnal. 2009;2:15-9.
  8. Antonini F, Pezzilli R, Angelelli L, Macarri G. Pancreatic disorders in inflammatory bowel disease. World J Gastrointest Pathophysiol. 2016;7:276- 82.
  9. Koh YY, Jeon WK, Cho YK, Kim HJ, Chung WG, Chon CU, et al. The effect of intestinal permeability and endotoxemia on the prognosis of acute pancreatitis. Gut Liver. 2012;6:505-11.
  10. McClave SA. Drivers of oxidative stress in acute pancreatitis: the role of nutrition therapy. J Parenter Enteral Nutr. 2012;1:24-35
  11. Qin HL, Zheng JJ, Tong DN, Chen WX, Fan XB, Hang XM, et al. Effect of Lactobacillus plantarum enteral feeding on the gut permeability and septic complications in the patients with acute pancreatitis. Eur J Clin Nutr. 2008;62(7):923-30.
  12. Wu XM, Ji KQ, Wang HY, Li GF, Zang B, Chen WM. Total enteral nutrition in prevention of pancreatic necrotic infection in severe acute pancreatitis. Pancreas. 2010;39(2):248-51.
  13. Dostieva ZA, Muradov AM, Shumilina OV. Vliyanie nepryamogo elektrokhimicheskogo okisleniya na pokazateli toksichnosti krovi u bol’nykh v toksicheskoy faze peritonita, obuslovlennogo pankreonekrozom [The effect of indirect electrochemical oxidation on blood toxicity indicators in patients with toxic phase of peritonitis caused by pancreatonecrosis]. Vestnik Avitsenny [Avicenna Bulletin]. 2013;1:28-32.
  14. Baal MC, Kohout Р, Besselink MG, van Santvoortc HC, Benesb Z, Zazulae R, et al. Probiotic treatment with Probioflora in patients with predicted severe acute pancreatitis without organ failure. Pancreatology. 2012;5(12):458-62.
  15. Sharma M, Sachdev V, Singh N, Bhardwaj P, Pal A, Kapur S, et al. Alterations in intestinal permeability and endotoxemia in severe acute pancreatitis. Trop Gastroenterol. 2012;33(1):45-50.
  16. Leal-Lopes C, Velloso FJ, Campopiano JC, Sogayar MC, Correa RG. Roles of commensal microbiota in pancreas homeostasis and pancreatic pathologies. Journal of Diabetes Research. 2015;1-20.
  17. Andryushchenko LV, Kunovskiy VV, Andryushchenko VP. Klinicheskie i patomorfologicheskie proyavleniya sindroma nedostatochnosti kishechnika v techenie ostrogo nekroticheskogo pankreatita [Clinical and pathological manifestations of intestinal insufficiency syndrome during acute necrotic pancreatitis]. Kharkívs’ka khírurgíchna shkola. 2010;3:5-7.
  18. Wei AL, Guo Q, Wang MJ, Hu WM, Zhang ZD. Early complications after interventions in patients with acute pancreatitis. World J Gastroenterol. 2016;22:2828-36.
  19. Kolesnik IP. Patomorfogenez sindroma kishechnoy nedostatochnosti pri ostrom pankreatite [Pathomorphogenesis of the syndrome of intestinal insufficiency in acute pancreatitis]. Ukrains’kiy zhurnal khírurgii. 2012;1:121-5.
  20. Kurbonov KM, Muminov S. Enteral’naya korrektsiya endotoksikoza pri rasprostranyonnom peritonite [Enteral correction of endotoxemia with widespread peritonitis]. Vestnik Avitsenny [Avicenna Bulletin]. 2016;1:17-20
  21. Fedoseev AV, Muravyov SYu, Budarev VN, Abuvarda FKh, Borisenko RS, Panina NYu, i dr. K voprosu diagnostiki rannikh priznakov poliorgannoy disfunktsii u bol’nykh s sindromom enteral’noy nedostatochnosti [To the question of the diagnosis of early signs of multiorgan dysfunction in patients with enteral insufficiency syndrome]. Vestnik eksperimental’noy i klinicheskoy khirurgii. 2012;5:60-4.
  22. Gomatos IP, Xiaodong X, Ghaneh P, Halloran C, Raraty M, Lane B, et al. Prognostic markers in acute pancreatitis. Expert Rev Mol Diagn. 2014;14(3):333-46.
  23. Amitai MM, Raviv-Zilka L, Hertz M, Erlich Z, Konen E, Ben-Horin S, et al. Main imaging features of Crohn’s disease: Agreement between MR-Enterography and CT-Enterography. Isr Med Assoc J. 2015;17:293-7.
  24. Liu H, Li W, Wang X, Li J, Yu W. Early gut mucosal dysfunction in patients with acute pancreatitis. Pancreas. 2008;36:192-6.
  25. . Mole DJ, Olabi B, Robinson V, Garden OJ, Parks RW. Incidence of individual organ dysfunction in fatal acute pancreatitis: analysis of 1024 death records. HPB (Oxford). 2009;2(11):166-70.
  26. Bagnenko SF, Goltsov VR. Ostryy pankreatit – sovremennoe sostoyanie problemy i nereshyonnye voprosy [Acute pancreatitis is the current state of the problem and unresolved issues]. Al’manakh Instituta khirurgii im. A.V. Vishnevskogo. 2008;3:104-12.
  27. Dibirov MD. Lechenie sindroma kishechnoy nedostatochnosti pri pankreonekroze [Treatment of intestinal insufficiency syndrome with pancreatic necrosis]. Effektivnaya farmakoterapiya. 2013;8:28-33.
  28. Fedoseev AV, Budarev VN, Abu Varda FKh. Optimizatsiya lecheniya bol’nykh s enteral’noy nedostatochnost’yu putyom korrektsii kishechnogo disbioza [Optimization of the treatment of patients with enteral insufficiency by correcting intestinal dysbiosis]. Moskovskiy khirurgicheskiy zhurnal. 2012;1:14-8.
  29. Alekseeva EV, Popova TS, Baranov GA, Pasechnik IN, Chuvanov MV. Prokinetiki v lechenii sindroma kishechnoy nedostatochnosti [Prokinetics in the treatment of intestinal failure syndrome]. Kremlyovskaya meditsina. Klinicheskiy vestnik. 2011;4:125-9.
  30. Mylnikov AG, Shapovalyants SG, Pankov AG, Korolyov SV. Enteral’noe zondovoe pitanie i selektivnaya dekontaminatsiya zheludochno-kishechnogo trakta v lechenii ostrogo destruktivnogo pankreatita [Enteral tube feeding and selective decontamination of the gastrointestinal tract in the treatment of acute destructive pancreatitis]. Khirurgiya. 2012;2(6):37-41.
  31. Besselink MG, van Santvoort HC, Renooij W, de Smet MB, Boermeester MA, Fischer K, et al. Intestinal barrier dysfunction in a randomized trial of a specific probiotic composition in acute pancreatitis. Ann Surg. 2009;5:712-9
  32. Hoque R, Sohail M, Malik A. TLR9 and the NLRP3 inflammasome link acinar cell death with inflammation in acute pancreatitis. Gastroenterology. 2011;1:358-69.
  33. Konovalov EP. Laktuloza: novyy perspektivnyy put’ korrektsii sindroma enteral’noy nedostatochnosti u khirurgicheskikh bol’nykh [Lactulose: a new promising way to correct the syndrome of enteral insufficiency in surgical patients]. Consilium Medicum Ukraina. 2008;2:46-8.
  34. Shibitov VA, Vlasova TI, Polozova EI, Vlasov PA, Anaskin SG, Matveeva MV. Patogeneticheskie osnovy enteral’noy nedostatochnosti [Pathogenetic bases of enteral insufficiency]. Fundamental’nye issledovaniya. 2012;4(1):152-6.
  35. Siplivyy VA, Grinchenko SV, Evtushenko DV, Mityakova YuS. Enteral’noe pitanie u khirurgicheskikh bol’nykh [Enteral nutrition in surgical patients]. Ukrains’kiy zhurnal khirurgii. 2011;3(12):50-4.
  36. Liu Y, Luo HS. Quantitative analysis of intestinal gas in patients with acute pancreatitis. Hepatobiliary Pancreat Dis Int. 2012;11:314-8.
  37. Fishman JE, Levy G, Alli V, Zheng X, Mole DJ, Deitch EA. The intestinal mucus layer is a critical component of the gut barrier that is damaged during acute pancreatitis. Shock. 2014;42(3):264-70.

Authors' information:

Ali-Zade Sukhrob Gaffarovich
Candidate of Medical Sciences, Assistant of the Department of Surgical Diseases № 1, Avicenna Tajik State Medical University

Nazarov Shokhin Kuvvatovich
Doctor of Medical Sciences, Full Professor, Head of the Department of Surgical Diseases № 1, Avicenna Tajik State Medical University

Kholmatov Pulat Kadyrovich
Candidate of Medical Sciences, Associate Professor, Associate Professor of the Department of Surgical Diseases № 1, Avicenna Tajik State Medical University

Dodikhudoev Rakhmatullo Alamshoevich
Postgraduate Student, Department of Surgical Diseases № 1, Avicenna Tajik State Medical University

Information about support in the form of grants, equipment, medications

The authors did not receive financial support from manufacturers of medicines and medical equipment.

Conflicts of interest: No conflict

Address for correspondence:

Ali-Zade Sukhrob Gaffarovich
Candidate of Medical Sciences, Assistant of the Department of Surgical Diseases № 1, Avicenna Tajik State Medical University

734003, Republic of Tajikistan, Dushanbe, Rudaki Ave., 139

Tel.: +992 (928) 217755

E-mail: suhrob_a@mail.ru

◄ Back to the list